Idiopathic Pulmonary Fibrosis

Latest News in Idiopathic Pulmonary Fibrosis

May 20, 2024

Toby Maher, MD, PhD: Improving Lung Function with ENV-101 Treatment of Idiopathic Pulmonary Fibrosis – MD Magazine

May 13, 2024

New Therapies in Development for Idiopathic Pulmonary Fibrosis (IPF) Address Existing Challenges With Diagnosis and Management – HMP Global Learning Network

May 9, 2024

Identification of CFH and FHL2 as biomarkers for idiopathic pulmonary fibrosis – Frontiers

April 24, 2024

Leech extract alleviates idiopathic pulmonary fibrosis by TGF-β1/Smad3 signaling pathway – ScienceDirect.com

April 17, 2024

Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis – Nature.com

122 Active Idiopathic Pulmonary Fibrosis Clinical Trials

As of November 12, 2024

Source: clinicaltrials.gov

LOCATE

CLINICAL TRIALS

BROWSE

FDA-approved DRUGS

FIND

A DOCTOR EXPERT™

WHAT IS

CONGRESS DOING?